AbbVie Inc. (ABBV)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 164.56 |
| Open | 165.37 |
| Bid | 162.75 x 800 |
| Ask | 163.62 x 1200 |
| Day's range | 162.50 - 165.71 |
| 52-week range | 130.96 - 182.89 |
| Volume | |
| Avg. volume | 5,604,850 |
| Market cap | 290.591B |
| Beta (5Y monthly) | 0.59 |
| PE ratio (TTM) | 49.08 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 6.20 (3.77%) |
| Ex-dividend date | 12 Apr 2024 |
| 1y target est | N/A |
- Zacks
Are You Looking for a High-Growth Dividend Stock?
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes? Let's find out.
- Zacks
AbbVie (ABBV) Boosts Neuropsychiatric Portfolio With New Deal
AbbVie (ABBV) inks an option-to-license and collaboration deal with Gilgamesh to develop next-generation therapies for psychiatric disorders.
- Zacks
Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know
Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.
© 2024 Yahoo. All rights reserved.